Militia Long/Short Equity ETF (ORR) Stock Price

31.475 ▼ -0.50 (-1.56%)
Open: 31.52 Vol: 21.37K Day's range: 31.35 - 31.56 Sep 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ORR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 31.80▼ 31.80▼ 31.80▼ 31.88▼ 31.67▼
MA10 31.84▼ 31.84▼ 31.83▼ 31.87▼ 31.46▲
MA20 31.83▼ 31.85▼ 31.86▼ 31.80▼ 30.18▲
MA50 31.95▼ 31.84▼ 31.76▼ 31.26▲ N/A    
MA100 31.72▼ 31.46▲ 31.20▲ 29.95▲ N/A    
MA200 30.46▲ 30.06▲ 29.79▲ N/A     N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.023▼ -0.031▼ -0.036▼ -0.069▼ 0.075▲
RSI 33.408▼ 33.922▼ 35.770▼ 46.109▼ 64.260▲
STOCH 45.203     45.203     49.954     27.433     69.248    
WILL %R -100.000▼ -100.000▼ -100.000▼ -91.776▼ -33.942    
CCI -204.866▼ -210.256▼ -208.234▼ -213.131▼ 57.328    
Latest Filters Detected On ORR
RSI $ORR RSI(14) Crossed Below 50 Set Alert
MA $ORR Price Crossed Below MA(26) Set Alert
MA $ORR Price Crossed Below MA(13) Set Alert
MA $ORR Price Crossed Below MA(7) Set Alert
▼ BREAK $ORR Price Breaks 10 Days Low Set Alert
CDL $ORR Hammer Candlestick Pattern Detected Set Alert
Militia Long/Short Equity ETF News
Nanobiotix-J&J Therapy Shows Promise In Tough Head And Neck Cancer
Tuesday, September 30, 2025 11:03 AM
Nanobiotix SA (NASDAQ:NBTX) on Tuesday announced updated data from cohorts 1 and 2 of Study 1100 Phase 1 dose escalation and expansion trial evaluating JNJ-1900 (NBTXR3) activated by radiation therapy ...
Nanobiotix-J&J Therapy Shows Promise In Tough Head And Neck Cancer
Tuesday, September 30, 2025 11:03 AM
Nanobiotix SA (NASDAQ:NBTX) on Tuesday announced updated data from cohorts 1 and 2 of Study 1100 Phase 1 dose escalation and expansion trial evaluating JNJ-1900 (NBTXR3) activated by radiation therapy ...
Merck: Initiating "Strong Buy" On Shift To Qlex SC Injection For Solid Tumors
Tuesday, September 30, 2025 06:53 AM
Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects for Merck. Read the latest analysis on the stock here.
ORR historical stock data
date open high low close volume
30/09/25 31.52 31.56 31.35 31.475 21,365
29/09/25 31.83 32.3242 31.70 31.975 20,216
26/09/25 31.96 32.105 31.90 31.969 7,800
25/09/25 31.91 32.04 31.89 32.0026 7,444
24/09/25 32.41 32.41 31.8901 31.97 20,795
23/09/25 31.86 31.988 31.80 31.9663 25,057
22/09/25 31.57 31.88 31.57 31.8155 42,455
19/09/25 31.81 31.81 31.61 31.6183 21,810
18/09/25 32.87 32.87 31.826 31.876 42,200
17/09/25 32.0937 32.20 31.98 32.0379 21,715
Quote Details
52wk Low:25.85
52wk High:32.87
Vol:21.37K
Avg Vol(3m):812.1K
1Y Chng:+0.00%
1M Chng:-1.12%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00